Miltenyi Biotec
| Primary URL | Location | Industry | miltenyibiotec[.]com |
Country
Germany
|
Pharmaceuticals
|
|---|
Profile
Miltenyi Biotec is a Germany-based biomedical research firm whose core activities encompass the development and supply of tools, technologies, and services for cellular research and therapy. The company operates within the life sciences sector, providing critical reagents, instruments, and clinical-grade solutions that support research in immunology, oncology, and regenerative medicine. A notable aspect of its work involves contributions to COVID-19 vaccine development, placing it within the front-line ecosystem responding to the global pandemic. Its operational scope is international, serving a worldwide customer base that includes academic research institutions, hospitals, and pharmaceutical companies. The firm's product portfolio is specialized, focusing on cell separation, cell culture, and molecular analysis technologies that are fundamental to advanced biomedical investigations and clinical applications.
The company's global footprint and the sensitive nature of its data were highlighted by a significant ransomware incident in November 2020. The Mount Locker ransomware gang attacked its IT infrastructure, causing widespread operational delays and impairing order processing across its international network. The attackers exfiltrated approximately 150 GB of data, a portion of which was leaked, confirming the company handles substantial volumes of proprietary and potentially sensitive research information. While Miltenyi Biotec restored most systems and contained the malware from spreading to external partners, the event caused residual email and telephone disruptions in some regions for a period, demonstrating the complexity of its distributed operations. The necessity to temporarily reroute customer communications through alternative channels further illustrates its integrated global supply and support chain. This incident underscores the company's position as a significant entity in the biomedical supply chain, where operational continuity and data security are directly linked to critical research and therapeutic development timelines. The recovery challenges faced for certain internal functions reflect the intricate nature of its specialized IT environment supporting scientific workflows.